Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3910 studies found for:    cholesterol
Show Display Options
Rank Status Study
21 Unknown  Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Dietary Supplement: Cholesterol supplementation
22 Completed Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
Condition: Smith-Lemli-Opitz Syndrome
Intervention: Drug: crystalline cholesterol oil-based suspension
23 Completed Cholesterol and Pharmacogenetic Study
Conditions: Hyperlipidemia;   Hypercholesterolemia;   Coronary Heart Disease;   Cardiovascular Disease
Intervention: Drug: Simvastatin
24 Completed Reverse Cholesterol Transport (RCT) Study
Condition: Healthy
Intervention: Other: 3H-Cholesterol
25 Completed BMS Reverse Cholesterol Transport (RCT) Study
Condition: Healthy
Intervention: Other: 3H-Cholesterol
26 Completed
Has Results
Effect of Beta-Glucan on Cholesterol Lowering
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Control;   Dietary Supplement: 3g LMW beta-glucan;   Dietary Supplement: 5g LMW beta-glucan;   Dietary Supplement: 3g HMW beta-glucan
27 Terminated Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
Condition: Elevated LDL Cholesterol
Interventions: Drug: Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril);   Drug: Simvastatin, ramipril, acetylsalicylic acid
28 Completed Impact of Buttermilk on Cholesterol Concentration and Homeostasis
Condition: Cardiovascular Disease
Intervention: Other: Buttermilk
29 Completed Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Wheat bran;   Dietary Supplement: 3g high MW;   Dietary Supplement: 4g medium MW;   Dietary Supplement: 3g medium MW;   Dietary Supplement: 4g low MW
30 Completed Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice
Conditions: Hypercholesterolemia;   Coronary Disease;   Primary Health Care;   Management, Risk
Intervention: Behavioral: HeartAge intervention
31 Completed Dose Effect of Limicol on (LDL)-Cholesterol Levels
Condition: Hypercholesterolaemia
Interventions: Dietary Supplement: Limicol;   Other: Placebo
32 Unknown  The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients
Condition: Hypercholesterolemia
Intervention: Other: LDL-cholesterol
33 Completed Cholesterol in ASD: Characterization and Treatment
Conditions: Autism;   Asperger Disorder;   PDD-NOS
Intervention: Other: Cholesterol
34 Completed Phytosterols, Ezetimibe, and Cholesterol Metabolism
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Intervention: Drug: Phytosterol-Deficient Diet, Ezetimibe 10 mg, Phytosterol Esters Containing 2000 mg Phytosterols
35 Terminated Efficacy of Prednisone in Patients With Severe Systemic Atheroembolism (Cholesterol Cristal Embolism)
Condition: Cholesterol Embolism Systemic
Interventions: Drug: prednisone;   Other: placebo
36 Completed A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)
Condition: Cholesterol
Interventions: Drug: ezetimibe;   Drug: Comparator: Placebo (unspecified);   Drug: simvastatin
37 Completed Comparison of Low and High Phytosterol Diets With Respect to Cholesterol Metabolism
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Intervention: Other: Low Phytosterol and High Phytosterol Diets
38 Withdrawn DLBS1449 in Diabetic Patients With Low HDL
Conditions: Diabetic Patients;   Low HDL-cholesterol (< 35 mg/dL);   Lifestyle Intervention for at Least 1 Month
Interventions: Drug: DLBS1449;   Other: Placebo
39 Completed Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia
Condition: Delivery of Health Care
Intervention: Dietary Supplement: Limicol (plant extract)
40 Active, not recruiting Trial Assessing Evolocumab(AMG145) Compared to LDL-C Apheresis in Subjects Receiving LDL-C Apheresis Prior to Study Enrollment
Condition: Hypercholesterolemia
Interventions: Biological: evolocumab (AMG 145);   Other: Low Density Lipoprotein Cholesterol (LDL-C) Apheresis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years